Format

Send to

Choose Destination
Cell Metab. 2012 May 2;15(5):585-94. doi: 10.1016/j.cmet.2012.04.002.

A ceramide-centric view of insulin resistance.

Author information

1
Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC 27704, USA. jose.chavez@dm.duke.edu

Abstract

The recent implementation of genomic and lipidomic approaches has produced a large body of evidence implicating the sphingolipid ceramide in a diverse range of physiological processes and as a critical modulator of cellular stress. In this review, we discuss from a historical perspective the most important discoveries produced over the last decade supporting a role for ceramide and its metabolites in the pathogenesis of insulin resistance and other obesity-associated metabolic diseases. Moreover, we describe how a ceramide-centric view of insulin resistance might be reconciled in the context of other prominent models of nutrient-induced insulin resistance.

PMID:
22560211
DOI:
10.1016/j.cmet.2012.04.002
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center